On the recordSeptember 16, 2015
It will be important that healthcare providers and patients have that same confidence in the safety and efficacy of FDA-approved biosimilars.
Source
congress.govEditor's note · Context
Emphasizing the need for confidence in biosimilars similar to generics.
Share
More from Susan Collins
Aug 5, 2026
I have carefully reviewed Todd Blanche's qualifications to be Attorney General. This includes his record and responses to questions from Senators at the Department of Justice Appropriations hearing, his confirmation hearing, and in the…
Jul 22, 2026
It appears that there is good faith on the Democratic side to try to pass the CR and avoid a government shutdown, which is always a disaster.
Jul 31, 2026
keeps the administration of important landmark education programs at the Department of Education — where Congress specifically put them and where they belong.
Other voices in this conversation
